| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Loewald
CEO | Chief Executive Officer | 63 | 07/09/2020 |
Robert Green
DFI | Director of Finance/CFO | 54 | 01/01/2020 |
Matthew Bio
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wayne Hewett
CHM | Chairman | 61 | 01/12/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 202.31Cr | ||
| -0.65% | -3.79% | +47.85% | +90.24% | 1,00100Cr | ||
| -0.29% | -4.62% | +51.08% | +65.41% | 64TCr | ||
| +0.83% | -1.19% | +21.49% | +72.54% | 45TCr | ||
| -0.38% | -3.45% | +29.35% | +34.09% | 34TCr | ||
| -0.09% | -14.68% | +11.22% | +27.14% | 26TCr | ||
| -0.43% | -3.61% | -1.73% | +7.95% | 25TCr | ||
| -1.34% | -15.03% | +35.49% | +45.45% | 21TCr | ||
| -3.44% | -8.32% | -21.27% | -59.20% | 20TCr | ||
| -0.75% | -4.96% | +24.70% | +89.11% | 18TCr | ||
| Average | -0.60% | -5.05% | +22.02% | +41.41% | 39.18TCr | |
| Weighted average by Cap. | -0.43% | -4.32% | +31.32% | +56.55% |
Employees
-
Sector
Pharmaceuticals
















